GLAXOSMITHKLINE PHARMACEUTICALS
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹960 Cr | ₹841 Cr | ₹2,476 Cr | ₹723 Cr | ₹647 Cr |
Adjustment | ₹-45 Cr | ₹-40 Cr | ₹-1,636 Cr | ₹-26 Cr | ₹13 Cr |
Changes In working Capital | ₹61 Cr | ₹-46 Cr | ₹120 Cr | ₹46 Cr | ₹44 Cr |
Cash Flow after changes in Working Capital | ₹976 Cr | ₹756 Cr | ₹959 Cr | ₹743 Cr | ₹704 Cr |
Cash Flow from Operating Activities | ₹582 Cr | ₹484 Cr | ₹811 Cr | ₹578 Cr | ₹490 Cr |
Cash Flow from Investing Activities | ₹8.71 Cr | ₹808 Cr | ₹-406 Cr | ₹418 Cr | ₹-57 Cr |
Cash Flow from Financing Activities | ₹-561 Cr | ₹-1,543 Cr | ₹-524 Cr | ₹-696 Cr | ₹-428 Cr |
Net Cash Inflow / Outflow | ₹29 Cr | ₹-251 Cr | ₹-119 Cr | ₹300 Cr | ₹6.03 Cr |
Opening Cash & Cash Equivalents | ₹35 Cr | ₹286 Cr | ₹405 Cr | ₹105 Cr | ₹99 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹64 Cr | ₹35 Cr | ₹286 Cr | ₹405 Cr | ₹105 Cr |
Compare Cashflow Statement of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹35,408.0 Cr | -6.3% | -9.4% | 4.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | -6.3% |
-9.4% |
4.9% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses